SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-021995
Filing Date
2018-03-28
Accepted
2018-03-28 20:57:20
Documents
2
Period of Report
2018-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5375
2 POA DOCUMENT poa.txt EX-24.3_780935 4293
  Complete submission text file 0001209191-18-021995.txt   11082
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNUM THERAPEUTICS 200 CAMBRIDGEPARK DR., STE. 3100 CAMBRIDGE MA 02140
Business Address
VASCONCELLES MICHAEL (Reporting) CIK: 0001734755 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 18720326